0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Radiation Emergency Medications Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-6P15869
Home | Market Reports | Health| Pharmacy
Global Radiation Emergency Medications Market Research Report 2023
BUY CHAPTERS

Global Radiation Emergency Medications Market Research Report 2025

Code: QYRE-Auto-6P15869
Report
June 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Radiation Emergency Medications Market

The global market for Radiation Emergency Medications was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Radiation emergency medications are pharmaceuticals used to treat individuals exposed to ionizing radiation during radiological or nuclear emergencies. Exposure to high levels of ionizing radiation can occur in incidents such as nuclear accidents, radiological attacks, or industrial accidents involving radioactive materials. Radiation can cause severe damage to cells and tissues, leading to acute radiation syndrome (ARS) or radiation sickness.
These medications aim to protect cells and tissues from the harmful effects of radiation. They can help minimize radiation-induced damage by scavenging free radicals and reducing oxidative stress. They can help reduce the severity of symptoms and improve outcomes for individuals exposed to radiation.
North American market for Radiation Emergency Medications is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Radiation Emergency Medications is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Radiation Emergency Medications include Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics, Mission Pharmacal, Partner Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Radiation Emergency Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiation Emergency Medications.
The Radiation Emergency Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Radiation Emergency Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiation Emergency Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Radiation Emergency Medications Market Report

Report Metric Details
Report Name Radiation Emergency Medications Market
Segment by Type
Segment by Application
  • Acute Radiation Syndrome(ARS)
  • Cancer Treatment
  • Radiation Exposure
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics, Mission Pharmacal, Partner Therapeutics, Myelo Therapeutics, Pluri
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Radiation Emergency Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Radiation Emergency Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Radiation Emergency Medications Market report?

Ans: The main players in the Radiation Emergency Medications Market are Amgen, Anbex, BTG International, Cellphire, Chrysalis BioTherapeutics, Darnitsa, Enzychem Lifesciences, Humanetics, Mission Pharmacal, Partner Therapeutics, Myelo Therapeutics, Pluri

What are the Application segmentation covered in the Radiation Emergency Medications Market report?

Ans: The Applications covered in the Radiation Emergency Medications Market report are Acute Radiation Syndrome(ARS), Cancer Treatment, Radiation Exposure, Others

What are the Type segmentation covered in the Radiation Emergency Medications Market report?

Ans: The Types covered in the Radiation Emergency Medications Market report are Potassium lodide (KI), Prussian Blue, DTPA (Diethylenetriamine Pentaacetate), Others

Recommended Reports

Radiation Therapy Devices

Radiation Protective Solutions

Emergency and Oncology

1 Radiation Emergency Medications Market Overview
1.1 Product Definition
1.2 Radiation Emergency Medications by Type
1.2.1 Global Radiation Emergency Medications Market Value Comparison by Type (2024 VS 2031)
1.2.2 Potassium lodide (KI)
1.2.3 Prussian Blue
1.2.4 DTPA (Diethylenetriamine Pentaacetate)
1.2.5 Others
1.3 Radiation Emergency Medications by Application
1.3.1 Global Radiation Emergency Medications Market Value by Application (2024 VS 2031)
1.3.2 Acute Radiation Syndrome(ARS)
1.3.3 Cancer Treatment
1.3.4 Radiation Exposure
1.3.5 Others
1.4 Global Radiation Emergency Medications Market Size Estimates and Forecasts
1.4.1 Global Radiation Emergency Medications Revenue 2020-2031
1.4.2 Global Radiation Emergency Medications Sales 2020-2031
1.4.3 Global Radiation Emergency Medications Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Radiation Emergency Medications Market Competition by Manufacturers
2.1 Global Radiation Emergency Medications Sales Market Share by Manufacturers (2020-2025)
2.2 Global Radiation Emergency Medications Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Radiation Emergency Medications Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Radiation Emergency Medications, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Radiation Emergency Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Radiation Emergency Medications, Product Type & Application
2.7 Global Key Manufacturers of Radiation Emergency Medications, Date of Enter into This Industry
2.8 Global Radiation Emergency Medications Market Competitive Situation and Trends
2.8.1 Global Radiation Emergency Medications Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Radiation Emergency Medications Players Market Share by Revenue
2.8.3 Global Radiation Emergency Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Radiation Emergency Medications Market Scenario by Region
3.1 Global Radiation Emergency Medications Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Radiation Emergency Medications Sales by Region: 2020-2031
3.2.1 Global Radiation Emergency Medications Sales by Region: 2020-2025
3.2.2 Global Radiation Emergency Medications Sales by Region: 2026-2031
3.3 Global Radiation Emergency Medications Revenue by Region: 2020-2031
3.3.1 Global Radiation Emergency Medications Revenue by Region: 2020-2025
3.3.2 Global Radiation Emergency Medications Revenue by Region: 2026-2031
3.4 North America Radiation Emergency Medications Market Facts & Figures by Country
3.4.1 North America Radiation Emergency Medications Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Radiation Emergency Medications Sales by Country (2020-2031)
3.4.3 North America Radiation Emergency Medications Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Radiation Emergency Medications Market Facts & Figures by Country
3.5.1 Europe Radiation Emergency Medications Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Radiation Emergency Medications Sales by Country (2020-2031)
3.5.3 Europe Radiation Emergency Medications Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Radiation Emergency Medications Market Facts & Figures by Region
3.6.1 Asia Pacific Radiation Emergency Medications Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Radiation Emergency Medications Sales by Region (2020-2031)
3.6.3 Asia Pacific Radiation Emergency Medications Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Radiation Emergency Medications Market Facts & Figures by Country
3.7.1 Latin America Radiation Emergency Medications Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Radiation Emergency Medications Sales by Country (2020-2031)
3.7.3 Latin America Radiation Emergency Medications Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Radiation Emergency Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Radiation Emergency Medications Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Radiation Emergency Medications Sales by Country (2020-2031)
3.8.3 Middle East and Africa Radiation Emergency Medications Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Radiation Emergency Medications Sales by Type (2020-2031)
4.1.1 Global Radiation Emergency Medications Sales by Type (2020-2025)
4.1.2 Global Radiation Emergency Medications Sales by Type (2026-2031)
4.1.3 Global Radiation Emergency Medications Sales Market Share by Type (2020-2031)
4.2 Global Radiation Emergency Medications Revenue by Type (2020-2031)
4.2.1 Global Radiation Emergency Medications Revenue by Type (2020-2025)
4.2.2 Global Radiation Emergency Medications Revenue by Type (2026-2031)
4.2.3 Global Radiation Emergency Medications Revenue Market Share by Type (2020-2031)
4.3 Global Radiation Emergency Medications Price by Type (2020-2031)
5 Segment by Application
5.1 Global Radiation Emergency Medications Sales by Application (2020-2031)
5.1.1 Global Radiation Emergency Medications Sales by Application (2020-2025)
5.1.2 Global Radiation Emergency Medications Sales by Application (2026-2031)
5.1.3 Global Radiation Emergency Medications Sales Market Share by Application (2020-2031)
5.2 Global Radiation Emergency Medications Revenue by Application (2020-2031)
5.2.1 Global Radiation Emergency Medications Revenue by Application (2020-2025)
5.2.2 Global Radiation Emergency Medications Revenue by Application (2026-2031)
5.2.3 Global Radiation Emergency Medications Revenue Market Share by Application (2020-2031)
5.3 Global Radiation Emergency Medications Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Radiation Emergency Medications Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Anbex
6.2.1 Anbex Company Information
6.2.2 Anbex Description and Business Overview
6.2.3 Anbex Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Anbex Radiation Emergency Medications Product Portfolio
6.2.5 Anbex Recent Developments/Updates
6.3 BTG International
6.3.1 BTG International Company Information
6.3.2 BTG International Description and Business Overview
6.3.3 BTG International Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BTG International Radiation Emergency Medications Product Portfolio
6.3.5 BTG International Recent Developments/Updates
6.4 Cellphire
6.4.1 Cellphire Company Information
6.4.2 Cellphire Description and Business Overview
6.4.3 Cellphire Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cellphire Radiation Emergency Medications Product Portfolio
6.4.5 Cellphire Recent Developments/Updates
6.5 Chrysalis BioTherapeutics
6.5.1 Chrysalis BioTherapeutics Company Information
6.5.2 Chrysalis BioTherapeutics Description and Business Overview
6.5.3 Chrysalis BioTherapeutics Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chrysalis BioTherapeutics Radiation Emergency Medications Product Portfolio
6.5.5 Chrysalis BioTherapeutics Recent Developments/Updates
6.6 Darnitsa
6.6.1 Darnitsa Company Information
6.6.2 Darnitsa Description and Business Overview
6.6.3 Darnitsa Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Darnitsa Radiation Emergency Medications Product Portfolio
6.6.5 Darnitsa Recent Developments/Updates
6.7 Enzychem Lifesciences
6.7.1 Enzychem Lifesciences Company Information
6.7.2 Enzychem Lifesciences Description and Business Overview
6.7.3 Enzychem Lifesciences Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enzychem Lifesciences Radiation Emergency Medications Product Portfolio
6.7.5 Enzychem Lifesciences Recent Developments/Updates
6.8 Humanetics
6.8.1 Humanetics Company Information
6.8.2 Humanetics Description and Business Overview
6.8.3 Humanetics Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Humanetics Radiation Emergency Medications Product Portfolio
6.8.5 Humanetics Recent Developments/Updates
6.9 Mission Pharmacal
6.9.1 Mission Pharmacal Company Information
6.9.2 Mission Pharmacal Description and Business Overview
6.9.3 Mission Pharmacal Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mission Pharmacal Radiation Emergency Medications Product Portfolio
6.9.5 Mission Pharmacal Recent Developments/Updates
6.10 Partner Therapeutics
6.10.1 Partner Therapeutics Company Information
6.10.2 Partner Therapeutics Description and Business Overview
6.10.3 Partner Therapeutics Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Partner Therapeutics Radiation Emergency Medications Product Portfolio
6.10.5 Partner Therapeutics Recent Developments/Updates
6.11 Myelo Therapeutics
6.11.1 Myelo Therapeutics Company Information
6.11.2 Myelo Therapeutics Description and Business Overview
6.11.3 Myelo Therapeutics Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Myelo Therapeutics Radiation Emergency Medications Product Portfolio
6.11.5 Myelo Therapeutics Recent Developments/Updates
6.12 Pluri
6.12.1 Pluri Company Information
6.12.2 Pluri Description and Business Overview
6.12.3 Pluri Radiation Emergency Medications Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Pluri Radiation Emergency Medications Product Portfolio
6.12.5 Pluri Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Radiation Emergency Medications Industry Chain Analysis
7.2 Radiation Emergency Medications Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Radiation Emergency Medications Production Mode & Process Analysis
7.4 Radiation Emergency Medications Sales and Marketing
7.4.1 Radiation Emergency Medications Sales Channels
7.4.2 Radiation Emergency Medications Distributors
7.5 Radiation Emergency Medications Customer Analysis
8 Radiation Emergency Medications Market Dynamics
8.1 Radiation Emergency Medications Industry Trends
8.2 Radiation Emergency Medications Market Drivers
8.3 Radiation Emergency Medications Market Challenges
8.4 Radiation Emergency Medications Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Radiation Emergency Medications Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Radiation Emergency Medications Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Radiation Emergency Medications Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Radiation Emergency Medications Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Radiation Emergency Medications Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Radiation Emergency Medications Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Radiation Emergency Medications Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Radiation Emergency Medications Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Radiation Emergency Medications, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Radiation Emergency Medications, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Radiation Emergency Medications, Product Type & Application
 Table 12. Global Key Manufacturers of Radiation Emergency Medications, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Radiation Emergency Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Emergency Medications as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Radiation Emergency Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Radiation Emergency Medications Sales by Region (2020-2025) & (K Units)
 Table 18. Global Radiation Emergency Medications Sales Market Share by Region (2020-2025)
 Table 19. Global Radiation Emergency Medications Sales by Region (2026-2031) & (K Units)
 Table 20. Global Radiation Emergency Medications Sales Market Share by Region (2026-2031)
 Table 21. Global Radiation Emergency Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Radiation Emergency Medications Revenue Market Share by Region (2020-2025)
 Table 23. Global Radiation Emergency Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Radiation Emergency Medications Revenue Market Share by Region (2026-2031)
 Table 25. North America Radiation Emergency Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Radiation Emergency Medications Sales by Country (2020-2025) & (K Units)
 Table 27. North America Radiation Emergency Medications Sales by Country (2026-2031) & (K Units)
 Table 28. North America Radiation Emergency Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Radiation Emergency Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Radiation Emergency Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Radiation Emergency Medications Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Radiation Emergency Medications Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Radiation Emergency Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Radiation Emergency Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Radiation Emergency Medications Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Radiation Emergency Medications Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Radiation Emergency Medications Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Radiation Emergency Medications Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Radiation Emergency Medications Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Radiation Emergency Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Radiation Emergency Medications Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Radiation Emergency Medications Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Radiation Emergency Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Radiation Emergency Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Radiation Emergency Medications Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Radiation Emergency Medications Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Radiation Emergency Medications Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Radiation Emergency Medications Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Radiation Emergency Medications Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Radiation Emergency Medications Sales (K Units) by Type (2020-2025)
 Table 51. Global Radiation Emergency Medications Sales (K Units) by Type (2026-2031)
 Table 52. Global Radiation Emergency Medications Sales Market Share by Type (2020-2025)
 Table 53. Global Radiation Emergency Medications Sales Market Share by Type (2026-2031)
 Table 54. Global Radiation Emergency Medications Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Radiation Emergency Medications Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Radiation Emergency Medications Revenue Market Share by Type (2020-2025)
 Table 57. Global Radiation Emergency Medications Revenue Market Share by Type (2026-2031)
 Table 58. Global Radiation Emergency Medications Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Radiation Emergency Medications Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Radiation Emergency Medications Sales (K Units) by Application (2020-2025)
 Table 61. Global Radiation Emergency Medications Sales (K Units) by Application (2026-2031)
 Table 62. Global Radiation Emergency Medications Sales Market Share by Application (2020-2025)
 Table 63. Global Radiation Emergency Medications Sales Market Share by Application (2026-2031)
 Table 64. Global Radiation Emergency Medications Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Radiation Emergency Medications Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Radiation Emergency Medications Revenue Market Share by Application (2020-2025)
 Table 67. Global Radiation Emergency Medications Revenue Market Share by Application (2026-2031)
 Table 68. Global Radiation Emergency Medications Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Radiation Emergency Medications Price (US$/Unit) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen Radiation Emergency Medications Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. Anbex Company Information
 Table 76. Anbex Description and Business Overview
 Table 77. Anbex Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Anbex Radiation Emergency Medications Product
 Table 79. Anbex Recent Developments/Updates
 Table 80. BTG International Company Information
 Table 81. BTG International Description and Business Overview
 Table 82. BTG International Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BTG International Radiation Emergency Medications Product
 Table 84. BTG International Recent Developments/Updates
 Table 85. Cellphire Company Information
 Table 86. Cellphire Description and Business Overview
 Table 87. Cellphire Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cellphire Radiation Emergency Medications Product
 Table 89. Cellphire Recent Developments/Updates
 Table 90. Chrysalis BioTherapeutics Company Information
 Table 91. Chrysalis BioTherapeutics Description and Business Overview
 Table 92. Chrysalis BioTherapeutics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Chrysalis BioTherapeutics Radiation Emergency Medications Product
 Table 94. Chrysalis BioTherapeutics Recent Developments/Updates
 Table 95. Darnitsa Company Information
 Table 96. Darnitsa Description and Business Overview
 Table 97. Darnitsa Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Darnitsa Radiation Emergency Medications Product
 Table 99. Darnitsa Recent Developments/Updates
 Table 100. Enzychem Lifesciences Company Information
 Table 101. Enzychem Lifesciences Description and Business Overview
 Table 102. Enzychem Lifesciences Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Enzychem Lifesciences Radiation Emergency Medications Product
 Table 104. Enzychem Lifesciences Recent Developments/Updates
 Table 105. Humanetics Company Information
 Table 106. Humanetics Description and Business Overview
 Table 107. Humanetics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Humanetics Radiation Emergency Medications Product
 Table 109. Humanetics Recent Developments/Updates
 Table 110. Mission Pharmacal Company Information
 Table 111. Mission Pharmacal Description and Business Overview
 Table 112. Mission Pharmacal Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mission Pharmacal Radiation Emergency Medications Product
 Table 114. Mission Pharmacal Recent Developments/Updates
 Table 115. Partner Therapeutics Company Information
 Table 116. Partner Therapeutics Description and Business Overview
 Table 117. Partner Therapeutics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Partner Therapeutics Radiation Emergency Medications Product
 Table 119. Partner Therapeutics Recent Developments/Updates
 Table 120. Myelo Therapeutics Company Information
 Table 121. Myelo Therapeutics Description and Business Overview
 Table 122. Myelo Therapeutics Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Myelo Therapeutics Radiation Emergency Medications Product
 Table 124. Myelo Therapeutics Recent Developments/Updates
 Table 125. Pluri Company Information
 Table 126. Pluri Description and Business Overview
 Table 127. Pluri Radiation Emergency Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Pluri Radiation Emergency Medications Product
 Table 129. Pluri Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Radiation Emergency Medications Distributors List
 Table 133. Radiation Emergency Medications Customers List
 Table 134. Radiation Emergency Medications Market Trends
 Table 135. Radiation Emergency Medications Market Drivers
 Table 136. Radiation Emergency Medications Market Challenges
 Table 137. Radiation Emergency Medications Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Radiation Emergency Medications
 Figure 2. Global Radiation Emergency Medications Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Radiation Emergency Medications Market Share by Type: 2024 & 2031
 Figure 4. Potassium lodide (KI) Product Picture
 Figure 5. Prussian Blue Product Picture
 Figure 6. DTPA (Diethylenetriamine Pentaacetate) Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Radiation Emergency Medications Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Radiation Emergency Medications Market Share by Application: 2024 & 2031
 Figure 10. Acute Radiation Syndrome(ARS)
 Figure 11. Cancer Treatment
 Figure 12. Radiation Exposure
 Figure 13. Others
 Figure 14. Global Radiation Emergency Medications Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Radiation Emergency Medications Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Radiation Emergency Medications Sales (2020-2031) & (K Units)
 Figure 17. Global Radiation Emergency Medications Average Price (US$/Unit) & (2020-2031)
 Figure 18. Radiation Emergency Medications Report Years Considered
 Figure 19. Radiation Emergency Medications Sales Share by Manufacturers in 2024
 Figure 20. Global Radiation Emergency Medications Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Radiation Emergency Medications Players: Market Share by Revenue in Radiation Emergency Medications in 2024
 Figure 22. Radiation Emergency Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Radiation Emergency Medications Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Radiation Emergency Medications Sales Market Share by Country (2020-2031)
 Figure 25. North America Radiation Emergency Medications Revenue Market Share by Country (2020-2031)
 Figure 26. United States Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Radiation Emergency Medications Sales Market Share by Country (2020-2031)
 Figure 29. Europe Radiation Emergency Medications Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Radiation Emergency Medications Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Radiation Emergency Medications Revenue Market Share by Region (2020-2031)
 Figure 37. China Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Radiation Emergency Medications Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Radiation Emergency Medications Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Radiation Emergency Medications Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Radiation Emergency Medications Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Radiation Emergency Medications Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Radiation Emergency Medications by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Radiation Emergency Medications by Type (2020-2031)
 Figure 56. Global Radiation Emergency Medications Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Radiation Emergency Medications by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Radiation Emergency Medications by Application (2020-2031)
 Figure 59. Global Radiation Emergency Medications Price (US$/Unit) by Application (2020-2031)
 Figure 60. Radiation Emergency Medications Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Multi-use Capsule-based Dry Powder Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O16568
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Jet Lag Medicine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0R20253
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ruxolitinib Phosphate Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3G16891
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global NaSSAs Antidepressants Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4B16895
Thu Sep 25 00:00:00 UTC 2025

Add to Cart